RNA N6-methyladenosine demethylase FTO promotes diabetic wound healing through TRIB3-mediated autophagy in an m6A-YTHDF2-dependent manner

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death and Disease vol. 16, no. 1 (Dec 2025), p. 222
Publicado em:
Springer Nature B.V.
Assuntos:
Acesso em linha:Citation/Abstract
Full Text - PDF
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000nab a2200000uu 4500
001 3182928474
003 UK-CbPIL
022 |a 2041-4889 
024 7 |a 10.1038/s41419-025-07494-3  |2 doi 
035 |a 3182928474 
045 2 |b d20251201  |b d20251231 
084 |a 274832  |2 nlm 
245 1 |a RNA N<sup>6</sup>-methyladenosine demethylase FTO promotes diabetic wound healing through TRIB3-mediated autophagy in an m<sup>6</sup>A-YTHDF2-dependent manner 
260 |b Springer Nature B.V.  |c Dec 2025 
513 |a Journal Article 
520 3 |a N6-methyladenosine (m6A) RNA modification impaired autophagy results in delayed diabetic wound healing. In this study, it was found that fat mass and obesity-associated protein (FTO) was significantly downregulated in the epidermis of diabetic patients, STZ-induced mice and db/db mice (type I and II diabetic mice) with prolonged hyperglycemia, as well as in different types of keratinocyte cell lines treated with short-term high glucose medium. The knockout of FTO affected the biological functions of keratinocytes, including enhanced apoptosis, inhibited autophagy, and delayed wound healing, producing consistent results with high-glucose medium treatment. High-throughput analysis revealed that tribbles pseudokinase 3 (TRIB3) served as the downstream target gene of FTO. In addition, both in vitro and in vivo experiments, TRIB3 overexpression partially rescued biological functions caused by FTO-depletion, promoting keratinocyte migration and proliferation via autophagy. Epigenetically, FTO modulated m6A modification in the 3’UTR of TRIB3 mRNA and enhanced TRIB3 stability in a YTHDF2-dependent manner. Collectively, this study identifies FTO as an accelerator of diabetic wound healing and modulates autophagy via regulating TRIB3 in keratinocytes, thereby benefiting the development of a m6A-targeted therapy for refractory diabetic wounds. 
653 |a Diabetes 
653 |a Keratinocytes 
653 |a 3' Untranslated regions 
653 |a Autophagy 
653 |a N6-methyladenosine 
653 |a Apoptosis 
653 |a Wound healing 
653 |a Hyperglycemia 
653 |a Cell lines 
653 |a mRNA stability 
653 |a Diabetes mellitus 
653 |a RNA modification 
653 |a Epidermis 
653 |a Body fat 
773 0 |t Cell Death and Disease  |g vol. 16, no. 1 (Dec 2025), p. 222 
786 0 |d ProQuest  |t Science Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3182928474/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3182928474/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch